Anti-tumor activity of the pan-FGFR inhibitor rogaratinib in patients with advanced urothelial carcinomas selected based on tumor FGFR mRNA expression levels-MedSci.cn

Anti-tumor activity of the pan-FGFR inhibitor rogaratinib in patients with advanced urothelial carcinomas selected based on tumor FGFR mRNA expression levels

Schuler, M; Nogova, L; Heidenreich, A; Tai, D; Cassier, P; Richly, H; Cho, BC; Sayehli, CM; Navarro, A; Bender, S; Ocker, M; Nogai, H; Wagner, A; Ince, S; Ellinghaus, P; Joerger, M

ANNALS OF ONCOLOGY, 2017; 28 ( ):

科室
- - 订阅+
  - 更多科室
工具
服务